BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12584467)

  • 21. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
    Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
    Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study.
    Adrych D; Kuźmiuk-Glembin I; Tylicki L; Heleniak Z; Garnier H; Wiśniewski J; Rutkowski P; Rutkowski B; Dębska-Ślizień A
    Transplant Proc; 2018; 50(1):155-159. PubMed ID: 29407301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
    Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH
    Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Post-transplant nephropathy and arterial hypertension].
    Oko A; Idasiak-Piechocka I; Czekalski S
    Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of posttranplant hypertension: ACE is trumped?
    Dudley CR
    Transplantation; 2001 Dec; 72(11):1728-9. PubMed ID: 11740380
    [No Abstract]   [Full Text] [Related]  

  • 27. [Correction of renovascular hypertension by extracorporeal reconstruction of the renal artery with an autologous kidney transplant].
    Belichenko IA; Arabidze GG; Kungurtsev VV; Kutsenko AV; Zeidlits LA
    Khirurgiia (Mosk); 1983 Apr; (4):80-2. PubMed ID: 6345911
    [No Abstract]   [Full Text] [Related]  

  • 28. [Arterial hypertension 2: Secondary forms of arterial hypertension].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2006 Jun; 95(24):965-74; quiz 975. PubMed ID: 16802506
    [No Abstract]   [Full Text] [Related]  

  • 29. Traditional drug therapy of hypertension in transplant recipients.
    Elliott WJ
    J Hum Hypertens; 1998 Dec; 12(12):845-9. PubMed ID: 9883707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is RAS blockade routinely indicated in hypertensive kidney transplant patients?
    Salzberg DJ
    Curr Hypertens Rep; 2007 Nov; 9(5):422-9. PubMed ID: 18177591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of surgical treatment of nephrogenic arterial hypertension].
    Kuska J; Nielubowicz J; Kokot F; Wiecek A
    Pol Arch Med Wewn; 1983 Feb; 69(2):113-21. PubMed ID: 6889149
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin-Converting Enzyme Inhibitors-Beneficial Effects Seen in Many Patient Groups May Not Extend to Kidney Transplant Recipients.
    Cross NB; Webster AC
    Transplantation; 2016 Mar; 100(3):472-3. PubMed ID: 26900806
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute transplant artery thrombosis induced by angiotensin-converting inhibitor in a patient with renovascular hypertension.
    Dussol B; Nicolino F; Brunet P; Leonetti F; Siles S; Berland Y
    Nephron; 1994; 66(1):102-4. PubMed ID: 8107938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric post-transplant hypertension: a review of current standards of care.
    Ingelfinger JA; Brewer ED
    Child Nephrol Urol; 1992; 12(2-3):139-46. PubMed ID: 1628272
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients.
    Büscher R; Vester U; Wingen AM; Hoyer PF
    Pediatr Nephrol; 2004 Nov; 19(11):1202-11. PubMed ID: 15365804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renovascular hypertension: 1979.
    Kaufman JJ; Marks LS; Maxwell MH
    Surg Annu; 1979; 11():313-61. PubMed ID: 388692
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventional Therapy for Transplant Renal Artery Stenosis Is Safe and Effective in Preserving Allograft Function and Improving Hypertension.
    Wang L; Liu B; Yan J; Wang Y; Wang W; Wang W; Chang H; Wang H; Wang C; Li Z; Li Y
    Vasc Endovascular Surg; 2017 Jan; 51(1):4-11. PubMed ID: 28100159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of hypertension in chronic renal failure.
    Maiorca R; Scolari F; Cancarini G; Brunori G; Camerini C
    Contrib Nephrol; 1987; 54():190-201. PubMed ID: 2882951
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.